Intra-Familial Clinical Heterogeneity due to FTLD-U with TDP-43 Proteinopathy Caused by a Novel Deletion in Progranulin Gene (PGRN)

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2011-01-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/JAD-2010-101413PMID 20930269PMCID PMC5045304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration.

  2010cited by this paper
• Prominent phenotypic variability associated with mutations in Progranulin.

  2009cited by this paper
• Corticobasal syndrome associated with a novel 1048_1049insG progranulin mutation

  2009cited by this paper
• “Frontotemporoparietal” dementia

  2009cited by this paper
• Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation

  2009cited by this paper
• Parkinsonism and impulse control disorder: Presentation of a new progranulin gene mutation

  2009cited by this paper
• Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members

  2009cited by this paper
• The molecular basis of frontotemporal dementia

  2009cited by this paper
• Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series

  2008cited by this paper
• A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.

  2008cited by this paper
• Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia

  2008cited by this paper
• Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.

  2008cited by this paper
• Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN).

  2008cited by this paper
• Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease

  2008cited by this paper
• A novel deletion in progranulin gene is associated with FTDP-17 and CBS.

  2008cited by this paper
• Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration

  2007cited by this paper
• Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With Progranulin Gene (PGRN) Mutations

  2007cited by this paper
• Progranulin in frontotemporal lobar degeneration and neuroinflammation

  2007cited by this paper
• Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.

  2007cited by this paper
• Late-onset frontotemporal dementia associated with a novel PGRN mutation

  2007cited by this paper
• Frontotemporal lobar degeneration: clinical and pathological relationships

  2007cited by this paper
• Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.

  2006cited by this paper
• Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia.

  2006cited by this paper
• Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

  2006cited by this paper
• Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

  2006cited by this paper
• Clinical and pathological characterization of progressive aphasia

  2006cited by this paper
• Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome.

  2006cited by this paper
• Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

  2006cited by this paper
• Nonsense-mediated mRNA decay: terminating erroneous gene expression.

  2004cited by this paper
• Mutation Screening of the MAPT and STH Genes in Polish Patients with Clinically Diagnosed Frontotemporal Dementia

  2003cited by this paper
• Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland.

  2003cited by this paper
• Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease.

  2001cited by this paper
• Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.

  1999cited by this paper
• Frontotemporal lobar degeneration

  1998cited by this paper
• Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.

  1994cited by this paper

• The Differential Effects of Genetic Mutations in ALS and FTD Genes on Behavioural and Cognitive Changes: A Systematic Review and Meta-Analysis

  2025cites this paper
• Generation and Characterization of Novel iPSC Lines from a Portuguese Family Bearing Heterozygous and Homozygous GRN Mutations

  2022cites this paper
• Clinical and neuropathological variability in the rare IVS10 + 14 tau mutation.

  2021cites this paper
• Positron emission tomography in vivo characterisation of the pathology of frontotemporal dementia

  2020cites this paper
• G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits

  2020cites this paper
• Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study

  2019cites this paper
• 10 Frontotemporal Lobar Degeneration

  2019cites this paper
• Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers

  2017cites this paper
• The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention

  2017cites this paper
• A network of RNA and protein interactions in Fronto Temporal Dementia

  2015cites this paper
• Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia

  2015cites this paper
• Differentiating between visual hallucination-free dementia with Lewy bodies and corticobasal syndrome on the basis of neuropsychology and perfusion single-photon emission computed tomography

  2014cites this paper
• Early-onset dementias: diagnostic and etiological considerations

  2013cites this paper
• Phenotypic Variability of Familial and Sporadic Progranulin p.Gln257Profs*27 Mutation

  2013cites this paper
• Psychosis and Hallucinations in Frontotemporal Dementia with the C9ORF72 Mutation: A Detailed Clinical Cohort

  2013cites this paper
• Estimating the Age of the Most Common Italian GRN Mutation: Walking Back to Canossa Times

  2012cites this paper
• Neuroprotective effects of progranulin in ischemic mice.

  2012cites this paper
• Losing protein in the brain: the case of progranulin.

  2012cites this paper
• Circulating progranulin as a biomarker for neurodegenerative diseases.

  2012cites this paper
• Phenotypic signatures of genetic frontotemporal dementia.

  2011cites this paper
• Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.

  2011cites this paper
• Parkinsonism and Frontotemporal Dementia: The Clinical Overlap

  2011cites this paper
• Frontotemporal Lobar Degeneration

  2011cites this paper